Exane Derivatives’s American Equity Investment Life Holding Company AEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,080
Closed -$64.4K 1083
2021
Q2
$64.4K Buy
+2,080
New +$65.7K 0.01% 609

Other funds holding AEL

Exane Derivatives's AEL Position: Q3 2021 in Review

Exane Derivatives sold out of American Equity Investment Life Holding Company (AEL) in Q3 2021, closing a stake of 2,080 shares — an estimated $64.4K sold.

Exane Derivatives first reported a position in AEL in Q2 2021 and held it in 1 quarter. The position peaked at $64.4K in Q2 2021. 213 funds tracked by Wall St. Rank hold AEL as of Q3 2021.

  • Exane Derivatives reported no remaining American Equity Investment Life Holding Company position as of Q3 2021 after selling out during the quarter.
  • Exane Derivatives sold 2,080 American Equity Investment Life Holding Company shares in Q3 2021, an estimated $64.4K.
  • Exane Derivatives first reported a position in American Equity Investment Life Holding Company in Q2 2021 and held it in 1 quarter.
  • Exane Derivatives's American Equity Investment Life Holding Company position peaked at $64.4K in Q2 2021.
  • 213 funds tracked by Wall St. Rank held American Equity Investment Life Holding Company as of Q3 2021.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.